EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
SteelPeak Wealth LLC Sells 94,279 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by Asset Management One Co. Ltd.
Gilead Sciences, Inc. $GILD Stock Position Lifted by Allspring Global Investments Holdings LLC
Gilead Sciences, Inc. $GILD is Verity & Verity LLC's 10th Largest Position - Daily Political
Gilead Sciences (NASDAQ:GILD) Upgraded to "Strong-Buy" at Wall Street Zen
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Bank Pictet & Cie Europe AG Boosts Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences Q3 EPS Forecast Raised by Zacks Research
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Lee Johnson Capital Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Ascent Group LLC Buys 11,926 Shares of Gilead Sciences, Inc. $GILD
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs
Daniel Patrick O'day Sells 10,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Google's Marc Berson appointed to Mastek Inc's Board of Directors
Diversified Trust Co Increases Holdings in Gilead Sciences, Inc. $GILD
Abacus FCF Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?
14 Best Pharma Dividend Stocks to Buy in 2026
Long-Term Stock Portfolio: 10 Best Stocks for the Next Decade
Sapient Capital LLC Sells 8,077 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Bought by E. Ohman J or Asset Management AB
Meyer Handelman Co. Has $38.56 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Highland Capital Management LLC Invests $1.76 Million in Gilead Sciences, Inc. $GILD
Meyer Handelman Co. Trims Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue
Norden Group LLC Has $3.40 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Brokerages
Does Gilead's 2025 Rally Match Its Cash Flow Outlook and Oncology Pipeline Prospects
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
Repare Therapeutics Sells Polymerase Theta ATPase Inhibitor To Gilead For Up To $30Mln
Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead | Morningstar
CAMBRIDGE, Mass. & MONTREAL -- (Business Wire) Repare T
Global X Japan Co. Ltd. Acquires 11,034 Shares of Gilead Sciences, Inc. $GILD
Vontobel Holding Ltd. Acquires 394,567 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Exchange Traded Concepts LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD
OFI Invest Asset Management Has $42.01 Million Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. $GILD Holdings Reduced by U.S. Capital Wealth Advisors LLC - Daily Political
Wall Street Zen Downgrades Gilead Sciences (NASDAQ:GILD) to Buy - Markets Daily
Wedge Capital Management L L P NC Sells 59,085 Shares of Gilead Sciences, Inc. $GILD
First Bank & Trust Sells 4,494 Shares of Gilead Sciences, Inc. $GILD - Daily Political
GILD: Extended HIV Exclusivity Will Support Stronger Long-Term Earnings Power
Gilead (GILD): Revisiting Valuation After HIV Wins and New U.S. Drug Pricing Agreement
Gilead Sciences (NASDAQ:GILD) Cut to "Buy" at Wall Street Zen
TrumpRx explained: How Trump's new drug price deals with 9 pharma companies could save patients money
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
Agreement addresses all requests by President Trump to reduc
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
Voya Investment Management LLC Purchases 426,743 Shares of Gilead Sciences, Inc. $GILD
NatWest Group plc Trims Position in Gilead Sciences, Inc. $GILD
Czech National Bank Acquires 11,080 Shares of Gilead Sciences, Inc. $GILD
Does Gilead Still Offer Value After Its 2025 Surge and Pipeline Progress?
Assenagon Asset Management S.A. Buys 2,169,266 Shares of Gilead Sciences, Inc. $GILD
Insider Selling: Gilead Sciences (NASDAQ:GILD) Insider Sells 3,000 Shares of Stock
Gilead Sciences (NASDAQ:GILD) CFO Andrew Dickinson Sells 3,000 Shares
Gilead Sciences Inc. (GILD) - Insider Monkey
Gilead Sciences, Inc. $GILD Shares Bought by Westwood Holdings Group Inc.
Gilead Sciences, Inc. $GILD Shares Sold by Texas Permanent School Fund Corp
Gilead Sciences, Inc. $GILD Shares Acquired by Orion Porfolio Solutions LLC
Kestra Investment Management LLC Acquires 9,551 Shares of Gilead Sciences, Inc. $GILD
National Bank of Canada FI Reduces Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences Reports Positive Phase 3 ARTISTRY-2 HIV Trial Results
Farmers Trust Co. Sells 11,071 Shares of Gilead Sciences, Inc. $GILD
Westwood Holdings Group Inc. Boosts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer
Thrivent Financial for Lutherans Sells 238,111 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Stock Position Trimmed by China Universal Asset Management Co. Ltd.
Kentucky Retirement Systems Decreases Stake in Gilead Sciences, Inc. $GILD - Daily Political
6,279 Shares in Gilead Sciences, Inc. $GILD Purchased by Rexford Capital Inc. - Daily Political
Why Arcus Biosciences (RCUS) Is Down 15.4% After Ending Key Gastric Cancer Trial And Pivoting Pipeline
Is Earlier Yescarta Use in Lymphoma Altering The Investment Case For Gilead Sciences (GILD)?
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $151.00 at Morgan Stanley
Gilead Sciences, Inc. $GILD Stock Position Decreased by Benjamin Edwards Inc. - Markets Daily
Gilead Sciences, Inc. $GILD Shares Sold by Benjamin Edwards Inc.
AQR Capital Management LLC Has $272.21 Million Stake in Gilead Sciences, Inc. $GILD
Ameriprise Financial Inc. Boosts Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by Adage Capital Partners GP L.L.C.
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00 - Markets Daily
Morgan Stanley Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - Stock Observer
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 - Stock Observer
BlueCrest Capital Management Ltd Buys Shares of 13,553 Gilead Sciences, Inc. $GILD - Daily Political
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Stock Traders Buy Large Volume of Gilead Sciences Call Options (NASDAQ:GILD)
Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD) - Markets Daily
Arcus Biosciences Shares Drop 12% After Discontinuing Phase 3 STAR-221 Trial
Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment - Update | Morningstar
Arcus Biosciences And Gilead Discontinue Phase 3 STAR-221 Study In Cancer Due To Futility
Gilead, Arcus scrap late-stage trial of cancer drug combo - Yahoo News Canada
Gilead Sciences, Inc. $GILD Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Gilead News
Germany's DAX Index Explodes 23% in 2025: how to trade DAX with Index CFDs?
Gold, silver surged in 2025: will precious metals continue to rise in 2026?
Top CFD Trading Platforms in 2026: markets.com, Plus500, eToro, Pepperstone
